Bellevue Group AG

Q2 2020 13F Detailed Holdings

Location
Kuesnacht, Switzerland
Holdings as of
6/30/2020
Value ($000)
$7,065,908
Num holdings
235
Date filed
8/13/2020
Form type
13F-HR
Prev filing
5/14/2020
Next filing
11/16/2020
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892